Melan-A/MART-1-specific CD8 T cells: from thymus to tumor
✍ Scribed by Mikaël J Pittet; Alfred Zippelius; Danila Valmori; Daniel E Speiser; Jean-Charles Cerottini; Pedro Romero
- Book ID
- 117787240
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 64 KB
- Volume
- 23
- Category
- Article
- ISSN
- 1471-4906
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A critical requirement for cancer vaccines is that they stimulate CD8 ؉ T cell responses. In this study, we tested the ability of a polyvalent melanoma vaccine to induce CD8 ؉ T cell responses to the melanoma associated antigens MAGE-3 and Melan A/MART-1. Fifteen HLA-A2 ؉ patients with resected mali
This study investigates the generation of primary melanoma cell-specific cytotoxic T lymphocytes (CTLs) in vitro. Induction of peptide-specific CTLs from unfractionated naive peripheral blood mononuclear cells from HLA-A2 healthy donors was assessed using 2 recently described 9-mer epitopes from the
## Abstract MHC class I tetramers containing peptide epitopes are sensitive tools for detecting antigen‐specific CD8^+^ T‐cell responses. We demonstrate here that binding of HLA‐A2 tetramers to CD8^+^ T cells specific for the melanoma‐associated antigen Melan‐A/MART‐1 can be fine‐tuned by altering